N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-1H-indole-3-carboxamide
C26H20FN7O — CID 118538911
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-1H-indole-3-carboxamide
N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-1H-indole-3-carboxamide (PubChem CID 118538911) has the molecular formula C26H20FN7O and a molecular weight of 465.49 g/mol. Its IUPAC name is N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-1H-indole-3-carboxamide.
Molecular Properties
| Compound Name | N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-1H-indole-3-carboxamide |
|---|---|
| PubChem CID | 118538911 |
| Molecular Formula | C26H20FN7O |
| Molecular Weight | 465.49 g/mol |
| Exact Mass | 465.17 |
| IUPAC Name | N-[6-[5-(4-fluorophenyl)-2,3-dimethylimidazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]-1H-indole-3-carboxamide |
| SMILES | Cc1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4c[nH]c5ccccc45)cn3n2)n1C |
| InChI | InChI=1S/C26H20FN7O/c1-15-29-24(16-7-9-17(27)10-8-16)25(33(15)2)21-11-12-23-30-22(14-34(23)32-21)31-26(35)19-13-28-20-6-4-3-5-18(19)20/h3-14,28H,1-2H3,(H,31,35) |
| InChIKey | NVZXZYRCZOJTKA-UHFFFAOYSA-N |
| XLogP | 4.98 |
| TPSA | 92.90 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 465.49 |
| LogP ≤ 5 | 4.98 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118538911 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.